Abstract
Concentrations of selenium and rubidium in groups of subjects with hyperthyroidism, carcinomas, or adenomas and in controls were determined by neutron activation analysis with coirradiated inorganic standards and IAEA reference material. Se was decreased in all pathological groups with the greatest modification in thyroids with carcinomas. Rb was elevated in all pathological groups with the greatest increase in carcinomas as well. According to the literature, Se has a protective effect on carcinogenity as well as on biochemical pathways in thyroid cells. There are no data in the literature on the effects of Rb in those cells. On the grounds of the present results, it seems possible to use the trapping of Rb for diagnostic purposes in cases of pathologically altered thyroids.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
J. Virtamo and J. K. Huttunen,Ann. Clin. Res. 17, 87 (1985).
G. F. Combs, Jr. and L. C. Clark,Nutr. Rev. 43, 325 (1985).
J. T. Salonen, G. Alfthan, J. K. Huttunen, and P. Puska,Amer. J. Epidemiol. 120, 342 (1984).
P. Knekt, A. Aromaa, J. Maatela, G. Alfthan, R. K. Aaran, M. Hakama, T. Haukulinen, R. Peto, and L. Teppo,J. Natl. Cancer Inst. 82, 864 (1990).
E. Glattre, S. Q. Thomassen, T. Haldorsen, P. G. Lung-Larsen, L. Theodorsen, and J. Aaseth,Int. J. Epidemiol. 18, 45 (1989).
Y. Thomassen and J. Aaseth,Selenium, M. Ihnat, ed., CRC Press, Boca Raton, FL, 1989.
J. Aaseth, H. Frey, E. Glattre, G. Norheim, J. Ringstad, and Y. Thomassen,Biol. Tr. Elem. Res. 24, 147 (1990).
J. Kvíčala, J. Havelka, J. Němec, and J. Zeman,J. Radioanal. Nucl. Chem. 149 257, (1991).
D. Behne, H. Hilmert, S. Scheid, H. Gessner, and W. Elger,Biochim. Biophys. Acta 966, 12 (1988).
L. Flohe and I. Brand,Biochim. Biophys. Acta 191, 541 (1969).
J. T. Rotruck, A. L. Pope, H. E. Ganther, A. B. Swanson, D. L. Hafeman, and W. G. Hoekstra,Science. 179, 558 (1973).
F. Carmignol, P. M. Sinet, and H. Jerome,Biochim. Biophys. Acta 759, 49 (1983).
P. C. Joselyn,Biochemistry of the SH Group, Academic, London, New York, 1972, p. 269.
D. Behne, S. Scheid, A. Kyriakopoulos, and H. Hilmert,Biochem. Biophys. Acta 1033, 219 (1990).
D. Behne, A. Kyriakopoulos, H. Meinhold, and J. Köhrle,Biochim. Biophys. Res. Commun. 173, 1143 (1990).
D. Behne, S. Scheid, H. Hilmert, H. Gessner, B. Gawlik, and A. Kyriakopoulos,Biol. Tr. Elem. Res. 26, 439 (1990).
H. L. Meltzer,J. Clin. Pharm. 31, 179 (1991).
J. M. Jones, O. Yeralan, G. Hines, M. Maher, D. W. Roberts, and R. W. Benson,Toxicol. Lett. 52, 163 (1990).
M. Petrini, F. Vaglini, G. Carulli, A. Azzara, F. Ambrogi, and B. Grassi,Haematologica 75, 27 (1990).
J. Kvíčala and J. Havelka,J. Radioanal. Nucl. Chem. 121, 261 (1988).
J. R. Arthur, F. Nicol, P. W. H. Rae, and G. J. Beckett,Clin. Chem. Enzym. Comms. 3, 209 (1990).
C. Bozzo, M. Goria, S. Marena, S. Avognina, and G. Pagano,Diabete Metab. 14, 646 (1988).
D. A. York, G. A. Bray, and Y. Yukimura,Proc. Natl. Acad. Sci USA 75, 477 (1978).
R. D. Perrone and D. E. McBride,Am. J. Physiol. 254, G898 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kvíčala, J., Havelka, J., Němec, J. et al. Selenium and rubidium changes in subjects with pathologically altered thyroid. Biol Trace Elem Res 32, 253–258 (1992). https://doi.org/10.1007/BF02784608
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02784608